Texas Yale Capital Corp’s CorMedix CRMD Stock Holding History

Texas Yale Capital Corp’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$126K	Hold	16,000	–	–	﹤0.01%	511
2026 Q1	$109K	Sell	16,000 -8,000	-33%	-$59.1K	﹤0.01%	499
2025 Q4	$279K	Hold	24,000	–	–	0.01%	425
2025 Q3	$279K	Buy	24,000 +2,000	+9%	+$24.2K	0.01%	424
2025 Q2	$271K	Buy	22,000 +2,000	+10%	+$22.1K	0.01%	410
2025 Q1	$123K	Hold	20,000	–	–	0.01%	441
2024 Q4	$162K	Buy	20,000 +4,000	+25%	+$40K	0.01%	448
2024 Q3	$129K	Buy	16,000 +4,000	+33%	+$21.6K	0.01%	446
2024 Q2	$52K	Buy	+12,000	New	+$61K	﹤0.01%	435

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Texas Yale Capital Corp's CRMD Position: Q2 2026 in Review

Texas Yale Capital Corp held its CorMedix (CRMD) position steady in Q2 2026 at 16,000 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

Texas Yale Capital Corp first reported a position in CRMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $279K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Texas Yale Capital Corp held 16,000 shares of CorMedix worth $126K as of Q2 2026.
Texas Yale Capital Corp left its CorMedix share count unchanged in Q2 2026.
CorMedix made up ﹤0.01% of Texas Yale Capital Corp's portfolio in Q2 2026, its #511 holding.
Texas Yale Capital Corp first reported a position in CorMedix in Q2 2024 and has held it in 9 quarters since.
Texas Yale Capital Corp's CorMedix position peaked at $279K in Q4 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.